Quanterix Corporation Restructuring and Related Cost, Number of Positions Eliminated
Quanterix Corporation (QTRX) reported Restructuring and Related Cost, Number of Positions Eliminated of 119 position for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2025-03-17
- Quanterix Corporation restructuring and related cost, number of positions eliminated for the quarter ending 2022-09-30 was 119.00 position.
- Quanterix Corporation restructuring and related cost, number of positions eliminated for fiscal 2024 was 119.00 position, a 0.00% change from fiscal 2023.
- Quanterix Corporation restructuring and related cost, number of positions eliminated for fiscal 2023 was 119.00 position, a 0.00% change from fiscal 2022.
- Quanterix Corporation restructuring and related cost, number of positions eliminated for fiscal 2022 was 119.00 position.
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 3 month | Restructuring and Related Cost, Number of Positions Eliminated 9 month | Restructuring and Related Cost, Number of Positions Eliminated 12 month |
|---|---|---|---|
| 2024-12-31 | 119.00 position 10-K · filed 2025-03-17 | ||
| 2023-12-31 | 119.00 position 10-K/A · filed 2024-12-26 | ||
| 2022-12-31 | 119.00 position 10-K · filed 2023-03-06 | ||
| 2022-09-30 | 119.00 position 10-Q · filed 2023-11-08 | 119.00 position 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |